Related Experiment Video
Updated: Jan 19, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer
Gianluca Civenni1, Giuseppina M Carbone1, Carlo V Catapano1
1Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.
Abstract:
The emergence of therapy-resistant cancer stem cells (CSCs) limit the efficacy of prostate cancer treatment. Using genetic knockdown and chemical inhibitors, we demonstrate the critical role of Bromodomain Containing 4 (BRD4) in promoting mitochondrial fission and sustaining CSC expansion. These findings provide a new paradigm for developing novel treatment strategies for prostate cancer.
Insights
Therapy-resistant prostate cancer stem cells (CSCs) hinder treatment. Bromodomain Containing 4 (BRD4) drives CSC expansion by promoting mitochondrial fission, offering new therapeutic targets.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Prostate cancer treatment efficacy is limited by therapy-resistant cancer stem cells (CSCs).
- Cancer stem cells are crucial for tumor recurrence and metastasis.
Purpose of the Study:
- To investigate the role of Bromodomain Containing 4 (BRD4) in the expansion and maintenance of prostate cancer stem cells.
- To explore the molecular mechanisms by which BRD4 influences cancer stem cell properties.
Main Methods:
- Utilized genetic knockdown techniques to reduce BRD4 expression in prostate cancer cells.
- Employed chemical inhibitors targeting BRD4 activity.
- Assessed the impact of BRD4 modulation on mitochondrial fission and CSC populations.
Main Results:
- Bromodomain Containing 4 (BRD4) was found to be critical for sustaining cancer stem cell expansion.
- BRD4 promotes mitochondrial fission, a process essential for cancer stem cell survival and proliferation.
- Inhibition of BRD4 led to decreased CSC populations.
Conclusions:
- Bromodomain Containing 4 (BRD4) plays a pivotal role in the biology of therapy-resistant prostate cancer stem cells.
- Targeting BRD4 and its downstream effects on mitochondrial dynamics presents a novel therapeutic strategy for prostate cancer.
- These findings open new avenues for overcoming treatment resistance in prostate cancer.
Related Concept Videos
07:16Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
06:48An Orthotopic Murine Model of Human Prostate Cancer Metastasis
05:07Intra-prostatic Injection of Cancer Cells: A Technique to Deliver Cancer Cells for Establishing Orthotopic Prostate Cancer Mouse Model
Nuclear Fission
07:01Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
11:29miRNA Expression Analyses in Prostate Cancer Clinical Tissues

